N/A
Completed N=8
IDEA Study Cognitive Stimulation Therapy (CST) Trial in Nigeria
Source: ClinicalTrials.gov NCT02233530 ↗Enrolled (actual)
8
Serious AEs
0.0%
Results posted
Jun 2021
Primary outcomePrimary: World Health Organization Brief Quality of Life Measure (WHOQOL-Bref) — 10.3 units on a scale
Summary
This trials of cognitive stimulation therapy (CST) in Tanzania is part of the larger Identification and Intervention for Dementia in Elderly Africans (IDEA) study.
The overall aim of the IDEA study is to set up and evaluate sustainable programmes to facilitate diagnosis of, and therapy for, people with dementia led by local communities in sub-Saharan Africa. The investigators seek to improve quality of life for people with dementia and their caregivers.
Within this trial of CST, the investigators hypothesise that CST can significantly improve the quality of people with dementia and their carers living in Africa
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY World Health Organization Brief Quality of Life Measure (WHOQOL-Bref) |
14.9 | — |
| SECONDARY WHOQOL Bref |
— | — |
| SECONDARY IDEA Cognitive Screen |
— | — |
| SECONDARY Hospital Anxiety and Depression Scale (HADS) |
— | — |
| SECONDARY Zarit Burden Interview (ZBI) |
— | — |
| SECONDARY Adapted Alzheimer's Disease Assessment Scale - Cognitive (ADAS-Cog) |
— | — |
| SECONDARY Study Specific Economic Evaluation |
— | — |
Eligibility Criteria
Inclusion Criteria
- Anyone with dementia living within the study site
Exclusion Criteria
- The participant and the family should have consented to take part in the study.
- Unable to travel to the centre where the CST sessions will be held due to physical impairment (e.g. bedbound or immobile)
- After assessment by the study doctor, deemed unable to engage in CST sessions (e.g. follow instructions and participate in activities) due to severe physical or cognitive impairment.
- Profound deafness
- Total blindness
- Aphasia - they should be able to understand verbal communication and communicate verbally (mild impairments are acceptable).
- The participant should be able to sit in a group setting for 1 hour.
- There should not be agitation, depression or psychosis to an extent that the person would not be able to tolerate spending time with other people in a group setting
Data sourced from ClinicalTrials.gov (NCT02233530). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.